Holding the lines
Our collection of cannabis cultivars is constantly growing and evolving. We curate the best novel phenotypes, without sacrificing the quality and uniformity expected from clonal varieties. Each year we test hundreds of diverse cultivars from large plant populations before making our final selections for growers and cultivators.
Robust testing for vigorous plants
To produce healthy cuttings for our customers, we follow strict cultivation protocols and use state-of-the-art methods to detect known and emerging pathogens. To ensure PCG plants are free from Hop Latent Viroid — identified as the prime causative agent of dudding — we developed our own molecular assay. Our HLVd OnSight diagnostic test allows high-throughput testing of our mother blocks, from that first formative cut all the way until harvest.
Seeds: Adapting our genetics for the future
As cannabis agriculture evolves, we recognize that large-acre farmers have needs distinct from smaller, craft growers. Seeds and seedlings of unique cultivars help them compete intelligently in a cutthroat marketplace. Using clones at scale makes no sense for large farms compared to the advantages of sowing seed. Seeds are cleaner, less prone to accumulating diseases, and demonstrate increased resistance to pests and environmental fluctuations. Seeds also have vigorous taproots, produce larger yields, with higher cannabinoid and terpene content.
Traditionally cannabis growers preferred clones, which was where we started. When we produced seed, it was primarily for regenerating and preserving older stock, and sometimes to produce new hybrid cuttings or CBD varieties. More recently, agronomic production systems propelled us to focus on seeds as starting germplasm for farmers, but also to shift our breeding programs to work alongside the large-scale production farms with whom we work. These large acreages allow us to breed our cultivars for yields per acre rather than plants per acre, climates rather than watts, and resistance to pests and diseases.
